EcoDrugPlus

Ensembl ID : ML05344a
Gene Symbol: -
External references: -
24 Possible Orthologues:

Ensembl ID : ML053634a
Gene Symbol: -
External references: -
44 Possible Orthologues:

Ensembl ID : ML13102a
Gene Symbol: -
External references: -
38 Possible Orthologues:

Ensembl ID : ML08863a
Gene Symbol: -
External references: -
53 Possible Orthologues:

Ensembl ID : ML08831a
Gene Symbol: -
External references: -
76 Possible Orthologues:

Ensembl ID : ML24281a
Gene Symbol: -
External references: -
68 Possible Orthologues:

Ensembl ID : ML25287a
Gene Symbol: -
External references: -
30 Possible Orthologues:

Ensembl ID : ML1541114a
Gene Symbol: -
External references: -
23 Possible Orthologues:

Ensembl ID : ML034326a
Gene Symbol: -
External references: -
195 Possible Orthologues:

Ensembl ID : ML05765a
Gene Symbol: -
External references: -
239 Possible Orthologues:

Ensembl ID : ML09663a
Gene Symbol: -
External references: -
255 Possible Orthologues:

Ensembl ID : ML050915a
Gene Symbol: -
External references: -
47 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).